No primary preventive strategies have been identified; secondary preventive measures are the most effective approach in dealing with PLE patients. They include the following.
Avoidance of ultraviolet radiation (UVR) exposure: this prevents the clinical manifestation of PLE; however, is often not feasible.[60]Ling TC, Dawe RS, Gardener E, et al. Interventions for polymorphic light eruption. Cochrane Database Syst Rev. 2017 Oct 9;2017(10):CD005069.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005069.pub3/full
Patients who meticulously photoprotect should be appropriately counselled regarding vitamin D replacement.[65]National Institute for Health and Care Excellence (NICE). Sunlight exposure: risks and benefits. February 2016 [internet publication].
https://www.nice.org.uk/guidance/ng34
Physical photoprotection: blocking the penetration of UVR on the skin by wearing thickly woven clothes, clothes with UVR filters, or using mineral sunscreens (e.g., with titanium dioxide).[66]Gies HP, Roy CR, Elliott G, et al. Ultraviolet radiation protection factors for clothing. Health Phys. 1994 Aug;67(2):131-9.
http://www.ncbi.nlm.nih.gov/pubmed/8026966?tool=bestpractice.com
[67]Diffey BL, Farr PM. Sunscreen protection against UVB, UVA and blue light: an in vivo and in vitro comparison. Br J Dermatol. 1991 Mar;124(3):258-63.
http://www.ncbi.nlm.nih.gov/pubmed/1805808?tool=bestpractice.com
Chemical photoprotection (sunscreens): the topical application of potent UV-A and UV-B filter systems, together with strong antioxidants, such as alpha-glucosylrutin (a naturally occurring flavonoid), and tocopheryl acetate (vitamin E), is available as a sunscreen. It effectively reduces the oxidative stress response to UVR in the skin, thus maintaining the homeostasis of the endogenous redox system and preventing the elicitation of clinical symptoms of PLE.[31]Hadshiew I, Stab F, Untiedt S, et al. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption. Dermatology. 1997;195(4):362-8.
http://www.ncbi.nlm.nih.gov/pubmed/9529558?tool=bestpractice.com
[44]Hadshiew IM, Treder-Conrad C, v. Bülow R, et al. Polymorphous light eruption (PLE) and a new potent antioxidant and UVA-protective formulation as prophylaxis. Photodermatol Photoimmunol Photomed. 2004 Aug;20(4):200-4.
http://www.ncbi.nlm.nih.gov/pubmed/15238098?tool=bestpractice.com
[68]McFadden N. UVA sensitivity and topical photoprotection in polymorphous light eruption. Photodermatol. 1984 Apr;1(2):76-8.
http://www.ncbi.nlm.nih.gov/pubmed/6531284?tool=bestpractice.com
Natural skin conditioning (hardening): although sometimes difficult to achieve without eliciting PLE symptoms, slow, repetitive exposure to natural sunlight can prevent the provocation of further symptoms. This method is not advisable due to the risk of provocation and skin malignancy.
Phototherapy: various regimens of phototherapy have been employed to induce skin conditioning, so-called hardening. Although UVB (broad-band and narrow-band), UV-A, UV-A plus UV-B, psoralen (8-methoxypsoralen) plus ultraviolet A (PUVA), and psoralen plus ultraviolet B (PUVB) have been used with varying degrees of success, they also bear the risk of inducing or aggravating PLE skin lesions.[17]Ros AM, Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatology. 1986 Oct;3(5):298-302.
http://www.ncbi.nlm.nih.gov/pubmed/3547354?tool=bestpractice.com
[44]Hadshiew IM, Treder-Conrad C, v. Bülow R, et al. Polymorphous light eruption (PLE) and a new potent antioxidant and UVA-protective formulation as prophylaxis. Photodermatol Photoimmunol Photomed. 2004 Aug;20(4):200-4.
http://www.ncbi.nlm.nih.gov/pubmed/15238098?tool=bestpractice.com
[69]Murphy GM, Logan RA, Lovell CR, et al. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br J Dermatol. 1987 Apr;116(4):531-8.
http://www.ncbi.nlm.nih.gov/pubmed/3555596?tool=bestpractice.com
[70]Bilsland D, George SA, Gibbs NK, et al. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol. 1993 Dec;129(6):708-12.
http://www.ncbi.nlm.nih.gov/pubmed/8286256?tool=bestpractice.com
[71]Berg M, Ros AM, Berne B. Ultraviolet A phototherapy and trimethylpsoralen UVA photochemotherapy in polymorphous light eruption - a controlled study. Photodermatol Photoimmunol Photomed. 1994 Aug;10(4):139-43.
http://www.ncbi.nlm.nih.gov/pubmed/7803223?tool=bestpractice.com
[72]Corbett, MF, Hawk JL, Herxheimer A, et al. Controlled therapeutic trials in polymorphous light eruption. Br J Dermatol. 1982 Nov;107(5):571-81.
http://www.ncbi.nlm.nih.gov/pubmed/6751374?tool=bestpractice.com
[73]Goulden V, Ling TC, Babakinejad P, et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022. Br J Dermatol. 2022 Sep;187(3):295-308.
https://academic.oup.com/bjd/article/187/3/295/6966564
Patients may experience sunburn reactions or even phototoxic responses with PUVA.[74]Morison WL, Marwaha S, Beck L. PUVA-induced phototoxicity: incidence and causes. J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):183-5.
http://www.ncbi.nlm.nih.gov/pubmed/9039165?tool=bestpractice.com
A short-term treatment course at the beginning of the summer might be sufficient to achieve effective results in some patients; however, the necessity for intense, repeated UVR exposures, with the goal of achieving prophylactic protection from clinical symptoms of PLE, might arise in some patients.[75]Menage P du H, Norris P, Cheong W, et al. Short course PUVA therapy is effective in polymorphic light eruption. Br J Dermatol. 1992;127:32.[76]Palmer RA, Friedmann PS. A comparison of six and 12 PUVA treatments in the prohylaxis of polymorphic light eruption. Clin Exp Dermatol. 2004 Mar;29(2):141-3.
http://www.ncbi.nlm.nih.gov/pubmed/14987268?tool=bestpractice.com
[60]Ling TC, Dawe RS, Gardener E, et al. Interventions for polymorphic light eruption. Cochrane Database Syst Rev. 2017 Oct 9;2017(10):CD005069.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005069.pub3/full
This increases the long-term risk of skin cancers and photo-ageing.[77]Stern RS, Vakeva LH. Noncutaneous malignant tumors in the PUVA follow-up study: 1975-1996. J Invest Dermatol. 1997 Jun;108(6):897-900.
http://www.ncbi.nlm.nih.gov/pubmed/9182818?tool=bestpractice.com
[78]Stern RS. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001 May;44(5):755-61.
http://www.ncbi.nlm.nih.gov/pubmed/11312420?tool=bestpractice.com
[79]Lindelof B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer: a large-scale epidemiological study. Lancet. 1991 Jul 13;338(8759):91-3.
http://www.ncbi.nlm.nih.gov/pubmed/1676477?tool=bestpractice.com
There are variable reports as to whether UV-B is preferred over PUVA. Guidelines suggest that PUVA should be considered if UV-B has failed, and it is preferable over systemic treatments.[80]Ling TC, Clayton TH, Crawley J, et al. British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015. Br J Dermatol. 2016 Jan;174(1):24-55.
http://onlinelibrary.wiley.com/doi/10.1111/bjd.14317/full
http://www.ncbi.nlm.nih.gov/pubmed/26790656?tool=bestpractice.com
Systemic prophylactic treatments: supplementation with omega-3 fatty acids showed some improvement of the severity of PLE symptoms.[62]Rhodes L, Durham B, Fraser W, et al. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin. J Invest Dermatol. 1995 Oct;105(4):532-5.
http://www.ncbi.nlm.nih.gov/pubmed/7561154?tool=bestpractice.com
A nutritional supplement containing lycopene, beta-carotene, and Lactobacillus johnsonii has also demonstrated molecular and clinical benefits.[63]Marini A, Jaenicke T, Grether-Beck S, et al. Prevention of polymorphic light eruption by oral administration of a nutritional supplement containing lycopene, β-carotene, and Lactobacillus johnsonii: results from a randomized, placebo-controlled, double-blinded study. Photodermatol Photoimmunol Photomed. 2014 Aug;30(4):189-94.
http://www.ncbi.nlm.nih.gov/pubmed/24283388?tool=bestpractice.com